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an nations there exists substantial variation in 
health [3,5,6], which as Nixon and Ulmann 
[7] note, is not explained by risk factors nor 
public health expenditures.
Coincident with the cross-country differences 
in health, there exists substantial variation in 
market structure across European countries 
and the United States. Specifically, over the 
last several decades, the United States has 
been characterized by a rise in large corpo-
rations and super-sized retail outlets. Unlike 
the U.S., European nations (Italy, France and 
Belgium in particular) have experienced a 
slower growth of hypermarkets, in part due to 
size-based entry regulation [8-11]. Studies by 
Rybczynski and Curtis [12] and Blanchard et 
al. [13] indicate a strong positive association 
between the prevalence of small business in 
a community and individual or community 
health. As such, we believe that market struc-
ture, as measured by the portion of small to 
total businesses in a nation, may have a role 
in explaining, at least in part, the observed 
cross-country differences in health. If a signi-
ficant association exists, this research should 
raise concern for European countries, like 
Italy, where the preference for small family 
CROSS-COUNTRY 
DIFFERENCES IN HEALTH
Recent evidence suggests that individual he-
alth is better in the United Kingdom than the 
United States despite lower spending on he-
alth care in the former [1]. Moreover, Banks 
et al. [1] report that substantial health dispa-
rities persist, even after controlling for socio-
economic status and risk factors. Indeed, the 
UK is not the only nation to have better health 
than the United States. Avendando et al. [2] 
find that among those aged 50 to 74, Ameri-
cans report worse health (i.e. cancer, diabe-
tes, stroke) than Europeans, and that health 
behaviours account for only a small portion 
of the cross-country gap. A health differential 
is apparent not only for those aged 50 to 74, 
but also for the general population. Across 
measures such as life expectancy, heart dise-
ase, and diabetes, Americans fare worse than 
the majority of their European counterparts 
[3]. For example, in 2009, life expectancy at 
birth was 82.3 in Switzerland, compared with 
78.2 in the U.S. [3]. Similar disparities are re-
ported in Or, 2000 [4], where differences re-
main despite controlling for socio-economic 









There is a well documented health disparity between several European countries and the United States. This health gap 
remains even after controlling for socioeconomic status and risk factors. At the same time, we note that the U.S. market 
structure is characterized by significantly more large corporations and "super-sized" retail outlets than Europe. Because big 
business is hierarchical in nature and has been reported to engender urban sprawl, inferior work environments, and loss of 
social capital, all identified as correlates of poor health, we suggest that differences in market structure may help account 
for some of the unexplained differences in health across Europe and North America. Using national level data, this study 
explores the relationship between market structure and health. We investigate whether individuals who live in countries 
with proportionately more small business are healthier than those who do not. We use two measures of national health: 
life expectancy at birth, and age-standardized estimates of diabetes rates. Results from ordinary least squares regressions 
suggest that, there is a large and statistically significant association between market structure (the ratio of small to total bu-
sinesses) and health, even after controlling income, public percent of health expenditure, and obesity rates. This association 
is robust to additional controls such as insufficient physical activity, smoking, alcohol disease, and air pollution. 
Keywords
Europe; United States; Health; Market structure; Small business
Can market structure 
explain cross-country 
differences in health?
Kate Rybczynski 1, Lori Curtis 1
1 Department of Economics, University of Waterloo
ORIGINAL 
RESEARCH
Farmeconomia. Health economics and therapeutic pathways 2013; 14(1): 33-43
© SEEd All rights reserved34 Farmeconomia. Health economics and therapeutic pathways 2013; 14(1)
Can market structure explain cross-country differences in health?
owned businesses, and accompanying size 
restricting legislation, is recently under scru-
tiny and change [10,11].
WHY SMALL BUSINESS 
MAY MATTER: PATHWAYS 
BETWEEN MARKET 
STRUCTURE AND HEALTH
A plethora of research exists on the determi-
nants of health at the individual and popu-
lation levels. Although causal relationships 
are difficult to prove [14,15], the accumu-
lation of evidence provides strong support 
for age, gender, income, education, marital 
status, health behaviours, availability of he-
alth care to be basic determinants of health 
(see for example, Mikkonen and Raphael, 
2010 [16] for excellent summary). Evidence 
from the Whitehall studies [17-19] is semi-
nal in introducing the relationship between 
social hierarchy and health. Their work indi-
cates a gradient in health status (subjective 
and objective; physical and psychological) 
among well-paid British civil servants. The 
Whitehall studies show that the gradient ap-
pears at even the highest employment grades 
and is thus not likely to be a matter of depri-
vation causing poor health. Evans and Stod-
dart [20] present a conceptual framework for 
the relationship between the determinants of 
health and population health and well-being 
still used by health researchers today to di-
scuss the determinants of both population 
and individual health (see for example Hur-
ley, 2010 [21]). These original studies laun-
ched an industry of research on the theme of 
hierarchies leading to the conclusion that hie-
rarchies (whether in a person’s employment, 
social or income status) are positively related 
to health (the higher on the ladder the better 
ones health – the gradient) but also that hie-
rarchies or inequalities lead to lower levels of 
population health, on average.
Research investigating the repercussions of 
modern, supersized, market structure has 
highlighted several factors of big business 
which are associated with health outcomes, 
both positively and negatively. For example, 
larger firm size brings economies of scale. As 
such, large companies can offer better me-
dical and dental benefits packages [13] and 
thus may have a positive impact on health. 
Major retail outlets are also associated with 
lower prices on health improving goods [22]. 
On the other hand, big business is thought 
to exacerbate several known correlates of 
poor health such as hierarchical work envi-
ronments, lack of control over work, isola-
tion, urban sprawl, and loss of social capital 
(see [12,13,18,23-30] for a detailed discus-
sion of these pathways). Indeed, Banks et al. 
[1] propose that the social circumstances in 
which people live and work may be key fac-
tors in the health differences across the UK 
and US, although they are unable to control 
for more than basic SES in their study.
Rybczynski and Curtis [12] take the original 
health gradient literature a step beyond SES 
and suggest that market structure may be an 
important underlying explanatory factor for 
health via its impact on social structure. The 
authors note that economic structure is at the 
heart of not only our work environment, but 
also our social norms and behaviours. Take, 
for example, Wilkinson’s hypothesis [31]: 
for the majority of human existence, we lived 
in hunter gatherer societies which are more 
egalitarian, with high levels of social interac-
tion and low chronic stress, and so our bodies 
perform best in such environments. Deaton 
[32] notes that at the heart of Wilkinson’s 
theory is an economic construct; lack of sto-
rage technology implied that sharing/recipro-
city were means by which meat from today 
could be turned into meat for tomorrow. Thus 
the social structure arose from the economic 
structure, the means of allocating scarce re-
sources.
Economic structure has changed dramatical-
ly over time, typically resulting in greater 
productivity and improved health [32]. But 
not all aspects of economic development are 
beneficial. For obvious reasons, as GDP was 
rising during the industrial revolution, health 
was declining [32]. Although the current su-
per-sized market structure has economies of 
scale which allow for health improvements, 
this structure also has characteristics which 
are associated with poor health. As such, 
we propose that the pattern of big business 
exhibited in the U.S., Canada, and some Eu-
ropean countries may be an underlying de-
terminant of the cross-country differences in 
health. To this end, we investigate the rela-
tionship between market structure and health 
outcomes at the national level.
Data
All data are aggregate (national level) and are 
obtained from one of five sources: the World 
Bank, the World Health Organization, natio-
nal Business Registry data for Canada, the 
national Statistics of U.S. Businesses for the 
United States, and Eurostat (for members of 
the European Union (EU) and European Free 
Trade Association (EFTA)). As is common in 
cross-country comparisons, we are limited by 
the available data. Specifically, we are limited 
by the number of countries that we can inclu-
de in our sample, because of the paucity of 
health and business indicators that are measu-
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red consistently across nations. Our choice of 
indicators, described in the following section, 
are measured in a consistent manner, and are 
in-line with what is found in previous studies.
Dependent variables
The first health outcome variable that we 
consider is an estimate of diabetes rates. Spe-
cifically, we use an age standardized estima-
te of the percent of the nation’s population 
which has a fasting glucose level at or above 
126 mg/dl (7.0 mmol/l) or is on medication 
for raised blood glucose. These data are avai-
lable for the year 2008 at the World Health 
Organization (WHO) data repository1. The 
second outcome variable we employ is life 
expectancy at birth, which was retrieved from 
the World Bank databank. Life expectancy at 
birth is an estimate of «the number of years a 
newborn infant would live if prevailing pat-
terns of mortality at the time of its birth were 
to stay the same throughout its life» [34]. The 
benefit of the former measure, raised blood 
glucose, is that it provides a specific, well de-
fined, measure of poor health which can be 
compared across countries. Also, using this 
variable generates consistency with Banks 
et al [1], for whom diabetes rates are a key 
measure. The drawback of using raised blood 
glucose is that it represents only one aspect 
of poor health. Thus, we incorporate a more 
general measure, life expectancy at birth, in 
order to capture a broader range of health 
outcomes. Both measures are based on spe-
cific biological markers, or estimates thereof, 
as opposed to self-reported measures, since 
self-reported health diagnoses may introduce 
a cultural bias to health differences [1,35].
Business count data
Our key independent variable is a measure of 
market structure. We define market structure 
as the ratio of the number of small to total 
businesses within a nation, where small is de-
fined as 1-9 employees. This variable is con-
structed from three distinct data sources. For 
the European countries, we obtain enterprise 
counts (by size) at Eurostat. For the U.S. we 
access the number of firms (by size) from the 
Statistics of U.S. Businesses, and for Cana-
da we retrieve establishment counts (by size) 
1 As with all age-standardizations, the data represents an 
estimate. Standardization is carried out by «applying the 
age-specific rates by sex in each population to one stan-
dard population. The WHO Standard Population, a fictitious 
population whose age distribution was artificially created 
and is largely reflective of the population age structure of 
low- and middle-income countries, was used. The resulting 
age-standardized rate, also expressed as a percentage of 
the total population, refers to the number of smokers per 
100 WHO Standard Population» [33]. Estimation, using 
country characteristics, is also employed when specific 
glucose data is unavailable.
from the Business Registry. Eurostat has 
made substantial efforts to ensure that the 
measures are consistent across countries; ho-
wever, there are notable differences between 
the definitions and unit of measurement re-
ported in the U.S. and Canada.
Statistics Canada [36] categorizes business 
registry data according to four distinct levels: 
enterprise, company, establishment and loca-
tion. The enterprise level is the legal unit or 
highest parent company linked by common 
ownership. However, public use Canadian bu-
siness registry data is available only at the esta-
blishment and location levels. Establishment 
level refers to a profit centre, or production 
entity, which produces a homogeneous set of 
goods or services, does not cross provincial 
boundaries and which provides data on the va-
lue of input and output. An establishment may 
consist of one or more locations. The location 
level is lowest single entity, within the busi-
ness structure, that provides revenue and/or 
employment data from production at a single 
geographical location. Two locations may be 
considered one establishment if information 
on revenue and input costs is only available at 
the aggregate level [37].
The definitions of the levels of business are 
markedly different in the United States. The 
Statistics of U.S. Businesses [38] defines 
an establishment as «a single physical loca-
tion where business is conducted». Business 
counts are reported at the firm level as well as 
the establishment level, where firm is defined 
as «a business organization consisting of one 
or more domestic establishments in the same 
state and industry that were specified under 
common ownership or control» [38]. In the 
U.S., the definition of “enterprise” differs 
from “firm” only in that there is no restriction 
on the industry or state boundaries for an en-
terprise. However, data is unavailable at the 
enterprise level.
In contrast to the Canadian and U.S. data, Eu-
rostat collects and reports business patterns 
data at the enterprise level. The Eurostat 
business patterns data is drawn from indivi-
dual nations’ business registers, harmonized 
to report at the enterprise level2, across most 
countries in the European Union and Europe-
an Free Trade Association. An enterprise is 
defined, as «the smallest combination of legal 
units that is an organisational unit producing 
goods or services, which benefits from a cer-
tain degree of autonomy in decision-making» 
2 Many countries report at the legal units level. In most cases, 
this is the same as the enterprise level [39]. As of 2002, most 
countries have co-operated with the harmonized collection 
of business data. For further information on harmonization, 
and compliance with OECD guidelines, please see [40-42]
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the public and primary sectors, and insurance 
activities of holding companies. Unlike Ca-
nadian and U.S. business data, Eurostat bu-
siness demographics are only available for 
most countries in 2008 and 2009.
Thus, to keep the data as consistent as pos-
sible across the U.S., Canada, and Eurostat 
countries, we make several restrictions on the 
business data before constructing the ratio of 
small to total businesses. For the Canadian 
and U.S. Business data we use establishment 
and firm level counts respectively, and exclu-
de the public and primary sectors.4 Because 
the criterion of employment is nearly univer-
sal among business registries, and because 
there is a great deal of variation in the crite-
rion of inclusion for non-employers between 
the U.S., Canada and Eurostat, we felt the 
most consistent sample restriction was to 
exclude all businesses with zero employees 
in Canada, the U.S., and Eurostat countries.5 
It should be expected that the ratio of small 
to total businesses is smaller when one re-
stricts the sample to exclude non-employers. 
6 However, we find that the difference in ra-
tios is quite similar across countries, the UK 
and Canada in particular, when we look at 
employers only versus non-employers. We 
perform one further sensitivity check to de-
termine whether using enterprise level versus 
location level data matters using U.S. and 
U.K. Business register data. Specifically we 
calculate the ratio of small to total busines-
ses at the enterprise versus location level. For 
both the U.K. and the U.S. enterprise/firm le-
vel counts result in slightly higher ratios than 
location level counts. Certainly, no matter 
which measure we use, the ratio of small to 
total businesses is consistently greater in the 
U.K. relative to the U.S. and Canada. Note 
that the Canadian Business Register data is 
available biannually in June and December. 
We use the June data for 2008 and 2009 sin-
ce, as of December 2009, the business regi-
stry no longer reports establishment counts.
Additional controls
Because our sample size is quite small, we 
choose a parsimonious set of control varia-
4 We have insufficient industry disaggregation to exclude the 
activities of holding companies at the firm level; however, 
restricting the activities at the establishment level has little 
impact on the ratio of small to total businesses.
5 We make this restriction by excluding the non-employer 
data in the U.S., the establishments in the indeterminant 
category in Canada, and enterprises with zero employees 
in the Eurostat countries. Eurostat has “employer only” data 
as well; however, the count ratios are identical, or nearly 
identical for all reporting countries.
6 Typically, non-employer firms would be considered small 
business if they were retained in the sample. So small would 
be defined at 0 to 9 employees.
[39], and may be a sole legal unit, consisting 
of one or more locations.
Similar to the North American registers, the 
Eurostat business patterns data is inclusive 
of almost all registered businesses. The tar-
get population of businesses in the Europe-
an registers varies slightly across countries. 
For example, the Value Added Tax (VAT) 
threshold, for inclusion in the sample, can 
vary across country. Moreover, some Eurostat 
countries restrict their sample to only include 
businesses with employees. Although there 
remain issues with respect to categorization 
of multinational businesses, and variation in 
VAT thresholds across region, Eurostat has 
made a concerted effort to harmonize data 
collection in the last decade, and estimates 
that most member countries have close to 99% 
coverage of their business population [40,41]. 
Coverage in Canada is likewise comprehen-
sive, the register includes any business that 
has been assigned an industry classification 
code and meets at least one of the following 
criteria: file corporate taxes, file individual 
taxes with positive business revenue, be re-
gistered for Goods and Services Tax (GST) 
with sales greater than zero, have at least one 
employee, or show evidence of size [36]. The 
target population for the U.S. is only slightly 
less broad. The Statistics of U.S. Businesses 
includes all employer firms that have filed a 
mid-March payroll [43]. However, data on 
establishments without employees is availa-
ble from the Census Bureau’s Non-employer 
statistics. Non-employer statistics cover all 
businesses which have no employees but are 
subject to federal income taxes, and have re-
ceipts of $1,000 or more [44].
All three sources of business demographics, 
the Statistics of U.S. Businesses, the Cana-
dian Business Register and Eurostat, provi-
de counts of establishments or enterprises 
by size in categories 1-4, 5-9 and 10 plus 
employees. Eurostat also has a category for 
enterprises with 0 employees, whereas Cana-
da uses a category titled “indeterminate” for 
businesses that have no work force data avai-
lable, because they have no workers, or they 
employ contract workers, family members or 
only owners.3
In terms of sectoral coverage, the Canadian 
Business Registry is the most comprehensive, 
including all sectors. The Statistics of U.S. 
Businesses (SUSB) includes most NAICS in-
dustries, but excludes most public sector and 
some primary sector industries. The most re-
strictive is the Eurostat data which excludes 
3 The U.S. and Canadian data also have further disaggrega-
tion of establishment size for greater than 10 employees.
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bles. In our preferred specification, we control 
for income, public health expenditure, and 
obesity rates. Income is represented by GDP 
per capita, adjusted for purchasing power pa-
rity, in 2005 constant international dollars. 
Our measure of public health expenditure is 
the public percent of total health expenditure. 
Both measures are retrieved from the World 
Bank databank [34]. We obtain age-standardi-
zed estimates of obesity rates from the WHO, 
where obesity is defined as a body mass in-
dex (BMI) of 30 kg/m2 or higher, based on 
measured height and weight, and the rate is 
defined out of the population aged 20 plus. 
These covariates, income, health expenditure 
and obesity, are among the most common in 
the individual, regional and aggregate level 
health gradient literature (see for example 
[1,2,5,6,45]) ; however, many studies are also 
able to employ measures of health behaviour 
(including obesity may be a way of indirectly 
controlling for poor health behaviours) and 
regional characteristics. Thus, in a less par-
simonious specification, we incorporate con-
trols for health risk factors. Specifically, we 
use three age-standardized estimates of na-
tional risk factors (procured from the WHO): 
percent of the adult population that are in-
sufficiently active; percent of the adult male 
population that have an alcohol disorder; and 
percent of the adult male population that cur-
rently smoke any tobacco product. Smoking 
includes daily or occasional smokers, alcohol 
disorders include diagnoses of harmful use 
of alcohol or alcohol dependence, the adult 
population is aged 15 plus, and insufficiently 
active is defined as «less than 5 times 30 mi-
nutes of moderate activity per week, or less 
than 3 times 20 minutes of vigorous activity 
per week, or equivalent» [33]. Unfortunately, 
the smoking and alcohol data are not availa-
ble for 2008, so our measures are based on the 
closest available years.
Many of the additional regional characteri-
stics which we would like to include (i.e. the 
unemployment rate, population dependency 
ratio, air pollution, Gini coefficient, ratio of 
health expenditure to GDP, predicted mean 
years of schooling, and percent urban) are 
strongly correlated with our existing regres-
sors. This multicollinearity problem is com-
mon among cross-country studies with small 
samples (see, for example Nixon and Ul-
mann, 2006 [7]). Thus, given our sample 
size, incorporating these controls would re-
sult in over-specification; however, we do 
check the sensitivity of our results to inclu-
sion of these covariates one by one and find 






Data source  
(years available)
% of population with raised glucose (fasting blood 
glucose ≥ 126 mg/dl, population aged 25+)
8.44 1.61 5.10 10.80 WHO (2008) [33]
Life expectancy at birth 77.93 3.25 71.81 81.39 World Bank (several) [34]
Ratio of small to total businesses 0.83 0.06 0.71 0.95 Eurostat, Canadian Business 
Register, Statistics of U.S. Businesses 
(2008, 2009) [36-42]
GDP/capita (PPP) (in 1000s) 29.82 13.08 11.78 73.35 World Bank (several) [34]
Public % of total Health Expenditure 72.43 10.86 41.51 84.29 World Bank (several) [34]
Obesity rate (age standardized)
(BMI ≥30, population aged 20+)
21.89 4.07 15.60 31.80 WHO (2008) [33]
% of population, aged 15+, that are insufficiently 
active (age standardized)
36.78 12.43 17.20 63.30 WHO (2008) [33]
% of male population, aged 15+, that have an 
alcohol use disorder (harmful use of alcohol or 
alcohol dependence)
6.01 3.70 0.50 15.29 WHO (2004) [33]
% of male population, aged 15+ that currently 
smokes any tobacco product (age standardized)
36.92 8.23 23.80 50.11 WHO (2009) [33]
Year 2008 (except for alcohol disorders data, which is 2004 only and male smokers 
data which is 2009 only)
Observations 25
Table I. Sample characteristics (Authors’ calculations from listed data sources. Excluded from the tables, but included in the 
sensitivity analysis were the following variables: IIASA/VID Projection-Mean years of schooling-age 15+ (total), percent of total 
population living in urban area, unemployment rate (as a percent of the labour force), total population, population dependency 
ratio (total population over 65 or under 15 as a percent of working aged population), and health expenditure as percent of GDP, all 
obtained from the World Bank. Gini coefficients were retrieved from the OECD and are not available annually, but for subsets of years. 
We use the late 2000s subset. Outdoor air pollution data (mean annual concentration of fine suspended particles of less than 10 
microns in diameter) was obtained from the WHO)
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rates of diabetes. The raw correlation is 
-0.309. In Figure 2, we note that life expec-
tancy is greater for countries with a larger 
share of small relative to total businesses. For 
these variables, the raw correlation is 0.237. 
Thus, before controlling for any national cha-
racteristics, the ratio of small to total busines-
ses appears to be positively associated with 
health.
However, this raw correlation may be driven 
by underlying differences among income or 
health systems in the individual countries. As 
such, we use ordinary least squares (OLS) 
regression analysis to determine whether the 
association (between market structure and 
Figure 1. Correlation between the percent of the population with raised blood glucose and the ratio of small to total businesses 
(Authors’ calculations using 2008 raised blood glucose data from the WHO, and business count data from Eurostat, the Canadian 
Business Register, and the Statistics of U.S. Businesses. Actual data points listed by country. Fitted values are denoted by the grey 
regression line. The raw correlation is -0.309)
Figure 2. Correlation between life expectancy (at birth) and the ratio of small to total businesses (Authors’ calculations using 2008 life 
expectancy data from the world bank, and business count data from Eurostat, the Canadian Business Register, and the Statistics of U.S. 
Businesses. Actual data points listed by country. Fitted values are denoted by the grey regression line. The raw correlation is 0.2365)
SAMPLE CHARACTERISTICS, 
METHODOLOGY, AND RESULTS
Sample characteristics are reported in Table 
I, where we note a five percentage point dif-
ference in the maximum and minimum dia-
betes rates, and a ten year difference in the 
highest and lowest life expectancies.
The ratio of small to total businesses, likewi-
se, spans a significant range, ranging from 
0.71 to 0.95. The standard deviation repre-
sents 25 percent of this range. Scatter plots of 
the relationship between market structure and 
health outcomes are presented in Figures 1 
and 2. Figure 1 indicates that countries with a 
greater portion of small business have lower 
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not reported in column (4), but are all statisti-
cally insignificant. Conversely, GDP per ca-
pita has a significant negative correlation 
with diabetes rates in most specifications. It 
should be noted that, by itself, public percent 
of health expenditure has a small negative as-
sociation with diabetes, but this association 
disappears once obesity rates are included in 
the specifications. Obesity rates, as one 
would expect, exhibit a strong and significant 
association with diabetes, but do not severely 
mitigate the coefficient on the ratio of small 
to total businesses. The estimated coefficient 
on the relationship between market structure 
and diabetes ranges from just over -10.8 to 
just over -7.9, with the latter estimate arising 
from the preferred specification. Using this 
preferred specification, column (3), the pre-
dicted percent of the population with raised 
blood glucose is 9.42% for a country with the 
lowest ratio of small to total businesses, 0.71, 
and all other characteristics at the mean. This 
percent falls to 7.51% for a country with the 
highest ratio of small businesses, 0.95, cete-
ris paribus. This 1.91 percentage point diffe-
rence in predicted diabetes rates covers just 
over one third of the difference between the 
maximum and the minimum diabetes rates.
Turning to Table III, we note similar results 
when our health outcome variable is life ex-
pectancy instead of diabetes. The association 
between life expectancy and market structure 
is positive, and is significant when the speci-
fication includes controls for GDP per capita 
and public percent of health expenditure. The 
strong significant association remains even 
with controls for obesity rates; however in-
corporation of controls for risk factors (al-
cohol disease in particular) lowers the 
strength and the significance of the estimated 
coefficient on market structure. In the more 
parsimonious specification, the coefficient 
estimate is above 21, whereas the larger spe-
(1) (2) (3) (4)
Ratio of small to total businesses -8.8839* (4.9249) -10.8273# (4.3460) -7.9496# (3.7995) -8.7981* (4.6451)
GDP/capita (PPP) in 1000s -- -0.0333* (0.0191) -0.0427# (0.0159) -0.0625 (0.0335)
Public % of total Health 
Expenditure
-- -0.0381* (0.0213) 0.0085 (0.0191) 0.0074 (0.0315)
Obesity rate (age standardized) -- -- 0.2808° (0.0643) 0.2777° (0.0607)
Risk Factors No No No Yes
Constant 15.8384° (4.1480) 21.2067° (3.6824) 9.5703* (5.1146) 9.7680 (6.1351)
R2 0.0956 0.2636 0.6616 0.6781
Observations 25 25 25 22
Table II. OLS Regressions of the percent of the population with raised blood glucose on the ratio of small to total businesses and 
other covariates. Estimated coefficients listed with standard errors in parentheses underneath. All regressions report robust standard 
errors. Significance at the one, five and ten percent level are denoted by °, #, and * respectively
health) remains after conditioning on income 
and public health expenditure. The following 
model is estimated, by OLS, for each health 
indicator:
HEALTHc = b0 + b1 * RATIOc + b2 * GDPc + 
b3 * PUBLICc + d * Xc + uc
where c is indexed across countries, RATIO 
represents the ratio of small to total busi-
nesses, GDP (measured in 1000s) refers to 
gross domestic product per capita adjusted 
for purchasing power parity, and PUBLIC is 
the percent of total health expenditure paid 
for by the public sector. X represents a set of 
additional covariats that (in various specifi-
cations) can include age standardized obesity 
rates and risk factors (such as age-standardi-
zed estimates the percent of the adult popula-
tion that are insufficiently active, the percent 
of the adult male population that have an al-
cohol disorder, and the percent of the adult 
male population that currently smoke any 
tobacco product), or alternatively the unem-
ployment rate, population dependency ratio, 
air pollution, Gini coefficient, ratio of health 
expenditure to GDP, predicted mean years of 
schooling, and percent urban. Finally, u is the 
country specific error term. HEALTH is mea-
sured first by age adjusted diabetes rates, then 
by life expectancy at birth.
Table II depicts coefficient estimates from li-
near regressions of diabetes rates on the ratio 
of small to total businesses, among other co-
variates. In column (2) we observe that the 
significant negative relationship between 
market structure and diabetes rates persists, 
even after controlling for GDP per capita and 
public percent of health expenditure. A signi-
ficant association also remains when we in-
clude obesity rates, in column (3), and when 
we control for health risk behaviours, in co-
lumn (4). Coefficients on the risk factors are 
© SEEd All rights reserved40 Farmeconomia. Health economics and therapeutic pathways 2013; 14(1)
Can market structure explain cross-country differences in health?
both Canada and the United States are exclu-
ded from the data (second column), a remar-
kably similar coefficient estimate persists. 
The third and fourth columns depict the re-
sults from regressing life expectancy on the 
ratio of small to total businesses, and other 
covariates, in samples that exclude Canada 
and North America respectively. Again, re-
sults are substantively similar. Therefore, we 
are fairly confident that our results are not an 
artefact of the differences in reporting stan-
dards across country.
DISCUSSION
The results presented here suggest that the-
re is a relationship between market structure 
and health that bears further investigation. 
Although this research does not identify a 
causal direction or specific pathway between 
market structure and health, the magnitude of 
the correlations suggests market structure is a 
worthwhile subject for future health research. 
A causal relationship would be suggestive of 
two broad policy approaches to improving 
national health: policies aimed at influencing 
market composition itself, and policies aimed 
at changing the work environments and the 
Dependent variable: % of population 
with raised blood glucose
Dependent variable: life 





Sample excludes  
Canada
Ratio of small to total businesses -7.8268* (4.0477) -7.8993* (4.1813) 26.5818° (6.2240)
GDP/capita (PPP) -0.0427# (0.0162) -0.0422# (0.0190) 0.1893° (0.0525)
Public % of total Health Expenditure 0.0085 (0.0192) 0.0075 (0.0227) -0.0106 (0.0321)
Obesity rate (age standardized) 0.2805° (0.0640) 0.2823° (0.0684) -0.1707 (0.1087)
Constant 9.4694* (5.2812) 9.5551* (5.3745) 54.4669° (7.3126)
R2 0.6540 0.6610 0.7022
Observations 24 23 24
Table IV. OLS Regressions of dependent variable on the ratio of small to total businesses and other covariates, with restricted 
samples, using the preferred specification (column 3). Estimated coefficients listed with standard errors in parentheses underneath. 
All regressions report robust standard errors. Significance at the one, five and ten percent level are denoted by °, #, and * respectively
population dependency ratio, air pollution, 
Gini coefficient, ratio of health expenditure 
to GDP, predicted mean years of schooling, 
and percent urban. The coefficient estimates 
for market structure remain large and negati-
ve and, for the majority of the specifications, 
are significant at the ten percent level or bet-
ter.
Finally, we investigate the sensitivity of our 
estimates to the inclusion of the U.S. and Ca-
nada. As stated previously, the target popula-
tion and the reporting of business demo-
graphics varies across country, but Canada 
has a particularly disparate report of business 
demographics as the data is based at the esta-
blishment, rather than at the firm or enterpri-
se level. Table IV reports the results of the 
sub-sample analysis. In the first column, the 
sample is restricted to exclude Canada, and 
we note that the estimated association betwe-
en market structure and diabetes rates re-
mains relatively unchanged. Likewise, if 
cification results in a coefficient estimate just 
below 10 which is significant at the 11% le-
vel (respectable given our small sample). Ho-
wever, it should be noted that there is a signi-
ficant time span between the measure of 
alcohol disease (2004) and the health outco-
me and market structure measures (2008). 
Using the preferred specification (column 3) 
to predict health outcomes, again we note lar-
ge differences across market structure. Pre-
dicted life expectancy in a country with a ra-
tio of small to total businesses at 0.71 is 75.26 
years, compared to a country with a ratio of 
0.95 where predicted life expectancy is 80.48 
years. This difference, of nearly five years, is 
close to half of the maximum cross-country 
difference in life expectancy.
For both health outcome variables, we consi-
der whether results are robust to the addition 
of alternative control variables. One at a time, 
we add the following covariates to our pre-
ferred specification: the unemployment rate, 
(1) (2) (2a) (3) (4)
Ratio of small to 
total businesses
8.6090 (12.218) 22.0222° (7.3442) 23.3531° (7.2415) 21.7603° (7.3340) 9.9442° (5.8822)
GDP/capita (PPP) 
in 1000s
-- 0.1869° (0.0563) 0.1869° (0.0584) 0.1921° (0.0575) 0.2825° (0.0451)
Public % of total 
Health Expenditure
-- 0.0248 (0.0236) 0.0127 (0.0255) -0.0131 (0.0299) 0.0355 (0.0302)
Obesity rate 
(age standardized)
-- -- -- -0.1555 (0.1001) -0.0571 (0.0561)
Risk Factors No No No No Yes
Years 2008 & 2009 2008 & 2009 2008 only 2008 only 2008 only
Constant 70.8619° (10.3646) 52.4209° (6.7300) 51.9903° (6.5477) 58.4308° (8.1036) 67.6754° (7.3588)
R2 0.0218 0.5944 0.6099 0.6398 0.9171
Observations 50 50 25 25 22
Table III. OLS Regressions of life expectancy (at birth) on the ratio of small to total businesses and other covariates. Estimated 
coefficients listed with standard errors in parentheses underneath. All regressions report robust standard errors, clustered at the 
country level for columns (1) and (2). Significance at the one, five and ten percent level are denoted by °, #, and * respectively.
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loss of social capital associated with super-
sized market structure.
In addition to the issue of causality, there are 
several other issues which we are unable to 
address in this study. First, we are unable 
to control for childhood or early life health 
factors. But existing research suggests that 
such controls are important since disease 
onset later in life is associated with childho-
od health [46,47]. Finally, we are aware that 
health gradients may vary along the income 
distribution, and this variation is a growing 
area of interest, particularly in Europe. Un-
fortunately the sample size in this study is too 
small for meaningful analysis along income 
quintiles. We suggest further microdata stu-
dies could shed light in this area.
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